Manulife (Manufacturers Life Insurance)
BSX.PRA

Manulife (Manufacturers Life Insurance)’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-91,453
Closed -$10.2M – 3042
2020
Q3 		$10.2M Sell
91,453
-11,847
-11% -$1.33M 0.01% 794
2020
Q2 		$10.7M Buy
+103,300
New +$11.1M 0.01% 753

Other funds holding BSX.PRA

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
RA
Rational Advisors Huntington, New York $1.09B AUM 11.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
CWM
Calamos Wealth Management Naperville, Illinois $3.31B AUM 32.95% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BSX.PRA Position: Q4 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q4 2020, closing a stake of 91,453 shares — an estimated $10.2M sold.

Manulife (Manufacturers Life Insurance) first reported a position in BSX.PRA in Q2 2020 and held it in 2 quarters. The position peaked at $10.7M in Q2 2020. 7 funds tracked by Wall St. Rank hold BSX.PRA as of Q4 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q4 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 91,453 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q4 2020, an estimated $10.2M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 2 quarters.
  • Manulife (Manufacturers Life Insurance)'s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $10.7M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q4 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.